Efficacy of tadalafil on symptom‐specific bother in men with lower urinary tract symptoms

Introduction This multicenter and prospective study was performed to evaluate the efficacy of tadalafil on patient‐reported bother for each symptom in men with lower urinary tract symptoms (LUTS). Methods Men with LUTS received 5 mg of tadalafil daily for 4 weeks. We assessed change in symptom severity using both international prostate symptom score (IPSS), and overactive bladder symptom score (OABSS), as well as patient‐reported quality of life (QOL: bother or satisfaction) for each symptoms using IPSS‐visual analog scale (IPSS‐VAS) and OABSS‐VAS. Results We found significant improvements in total IPSS (P